Your session is about to expire
← Back to Search
Behavioural Intervention
GuessWhat Mobile App Therapy for Autism
N/A
Waitlist Available
Led By Dennis P Wall, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through week 4 (assessed at week 4)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the GuessWhat mobile app, which has games to help children with Autism Spectrum Disorder (ASD) improve their social and emotional skills. It targets children aged 3-12 with ASD. The games help kids practice understanding emotions and social cues in a fun way.
Who is the study for?
This trial is for parents over 18 with a child aged 3-12 diagnosed with Autism Spectrum Disorder. The parent must be able to read English and have an iOS or Android smartphone compatible with the GuessWhat Mobile App.
What is being tested?
The study tests the effectiveness of the GuessWhat Mobile App, which offers games designed for behavioral therapy in children with autism. Families will use their smartphones to engage their child in these therapeutic games as per a set schedule.
What are the potential side effects?
Since this intervention involves using a mobile app for therapy, there are no direct medical side effects. However, screen time considerations and ensuring engagement without causing frustration are important factors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline through week 4 (assessed at week 4)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through week 4 (assessed at week 4)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Parent Reported Socialization Based on the Vineland Adaptive Behavior Scales 3rd Edition (VABS-3) Parent/Caregiver Socialization Subscale, From Baseline to Week 4
Secondary study objectives
Change in Emotion Recognition From Baseline to Week 4
Change in Parental Stress Scale - From Baseline to Week 4
GuessWhat App Usage Data
Other study objectives
mobile autism risk assessment score at baseline
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
The GuessWhat app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen. Participants will use their own personal phone to download the study app. Parent and child will be encouraged to play using the emojis and emotion game mode at least 3 individual game sessions per week. Parents are asked to play GuessWhat with their child 3-4 times per week for 4 weeks.
Group II: Treatment as UsualActive Control1 Intervention
Participants in control group will continue their treatment as usual.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GuessWhat Mobile App
2021
N/A
~550
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral therapies for Autism Spectrum Disorder (ASD), such as Applied Behavior Analysis (ABA) and the Early Start Denver Model (ESDM), work by reinforcing desired behaviors and reducing unwanted behaviors through structured, repetitive activities and positive reinforcement. These therapies often incorporate play and social interaction to improve communication, social skills, and adaptive behaviors.
Interactive games, like those in the GuessWhat app, engage children in fun, motivating activities that promote learning and development. Early and intensive behavioral interventions can lead to significant improvements in language, cognitive, and social functioning, which are critical for the overall development and quality of life of ASD patients.
Pivotal response treatment for preschoolers with autism spectrum disorder: Defining a predictor profile.Neurologic treatment strategies in autism: an overview of medical intervention strategies.Comparison of behavioural and natural play interventions for young children with autism.
Pivotal response treatment for preschoolers with autism spectrum disorder: Defining a predictor profile.Neurologic treatment strategies in autism: an overview of medical intervention strategies.Comparison of behavioural and natural play interventions for young children with autism.
Find a Location
Who is running the clinical trial?
National Library of Medicine (NLM)NIH
40 Previous Clinical Trials
107,136 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
Stanford UniversityLead Sponsor
2,471 Previous Clinical Trials
17,501,237 Total Patients Enrolled
36 Trials studying Autism Spectrum Disorder
3,296 Patients Enrolled for Autism Spectrum Disorder
Dennis P Wall, PhDPrincipal InvestigatorStanford University
5 Previous Clinical Trials
1,280 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
1,280 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The study is looking for children who are between 3 and 12 years old and have autism at the start of the study.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger